COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
Original Article
[키워드] absence
Arthritis
Autoimmune
Autoimmune systemic diseases
comparison
condition
conditions
Connective tissue diseases
COVID-19
develop
Diagnosis
disease
disease-modifying anti-rheumatic drug
Disease-modifying anti-rheumatic drugs
General population
generally mild
geographical area
impairment
Infection
Inflammatory
Interaction
investigated
Italian
Italian patient
manifestation
Manifestations
measure
medium
methotrexate
multicenter
overlapping
pandemic
Patient
Point
positive
Prevalence
protective role
Region
Result
Rheumatic diseases
SARS-CoV-2
significantly higher
stimulate
susceptibility
Swab test
symptomatic COVID-19
Symptoms
systemic disease
systemic diseases
tissue
Treatment
Tuscany
Virological
virus
[DOI] 10.1007/s10067-020-05334-7 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1007/s10067-020-05334-7 PMC 바로가기 [Article Type] Original Article